Groove Biopharma's Series B Round

Groove Biopharma raised a round of funding on December 05, 2011.

Groove Biopharma, fka Mirina Corporation, develops therapeutics using Minor Groove Binder Technology (MGB) to affect cellular processes involving microRNAs. Groove holds a license to the technology fr…

Articles about Groove Biopharma's Series B Round: